This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Arizona. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Tyler Ripperger: Innovator in SARS-CoV-2 Detection
Introduction
Tyler Ripperger is an accomplished inventor based in Tucson, AZ. He has made significant contributions to the field of medical diagnostics, particularly in the detection of SARS-CoV-2 antibodies. His innovative work has the potential to enhance the understanding and management of COVID-19.
Latest Patents
Tyler Ripperger holds a patent for "Serological assays for SARS-CoV-2." This patent describes a test system that includes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. The patent also outlines methods for detecting SARS-CoV-2 antibodies in a sample using this test system. He has 1 patent to his name.
Career Highlights
Tyler Ripperger is affiliated with the University of Arizona, where he contributes to research and development in the field of virology. His work is instrumental in advancing diagnostic techniques that are crucial for public health.
Collaborations
Some of his notable coworkers include Matthew Kaplan and Jennifer Uhrlaub. Their collaborative efforts contribute to the innovative research environment at the University of Arizona.
Conclusion
Tyler Ripperger's contributions to the field of SARS-CoV-2 detection exemplify the impact of innovative thinking in medical diagnostics. His work not only advances scientific knowledge but also plays a vital role in addressing public health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile